一氧化氮合成酶抑制剂对糖尿病肾病及其它肾病的影响
摘要
由于一氧化氮具有强烈的扩血管作用。其在不同的肾脏疾病中起到保护和非保护的作用。本文就一氧化氮合成酶抑制剂在调节糖尿病肾病早期肾内一氧化氮水平及其对糖尿病肾病血流动力学、肾功能改变的影响作以简要总结,并归纳了近年来一氧化氮合成酶抑制剂在其它肾脏疾病中的影响。
出处
《国外医学（老年医学分册）》
2003年第6期279-282,共4页
Foreign Medical Sciences(Geriatrics)
参考文献14
-
1Choi KC, Lee SC, Kim SW et al. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats. Korean J Intern Med, 1996; 14 (1): 32-41.
-
2Veelken R, Hilgers KF, Hartner A et al. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol, 2000; 11 (1): 71-79.
-
3Kasai N, Sugimoto K, Horiba N et al. Effect of D-glucose on nitric oxide release from glomerular endothelial cells. Diabetes Metab Res Rev, 2001;17 (3): 217-222.
-
4Komers R, Lindsley JN, Oyama TT et al. Role of neuronal nitric oxide synthase(NOSI) in the pathogenesis of renal hemodynamic changes in diabetes. Am J Physiol Renal Physiol,2000; 279 (3): F573-583.
-
5Noh H, Ha H, Yu MR et al. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fibronectin production. Nephron , 2002;90 (1): 78-85.
-
6Prabhakar SS. Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol Renal Physiol, 2001; 281 (1): F179-188.
-
7Dran GI, Fernandez GC, Rubd CJ et al. Protective role of nitric oxide in mice with Shiga toxin - induced hemolytic uremic syndrome. Kidney Int, 2002; 62 (4): 1338-1348.
-
8Watannabe S, Ono H, Ishimitsu T et al. Calcium antagonist inhibits glamerular cell apoptcsis and injuries of L- NAME exacerbated nephrosclerosis in SHR. Hypertens Res, 2000; 23(6): 683-691.
-
9Inada H, Ono H, Minami J et al. Nipradilol prevents L-NAME - exacerbated nephrosclerosis with decreasing of caspase -3 expression in SHR. Hypertens Res, 2002; 25 (3): 433-440.
-
10Mandarim-de-Lacerda CA, Pereira LM. Renal cortical remodelling by NO-synthesis blockers in rats is prevented by angiotensin-connverting enzyme inhibitor and calcium channel blocker.Cell Mol Med, 2001; 5 (3): 276-283.
-
1白建平.在败血症休克病人一氧化氮合成酶抑制剂氯化L—N^G—甲基精氨酸的药动力学[J].大同医学专科学校学报,2000,20(1):69-70.
-
2张茵,杨跃进.一氧化氮合成酶抑制剂在急性心肌梗死心原性休克中的应用进展[J].中国分子心脏病学杂志,2005,5(1):434-436.
-
3钱琪,方水林.方水林治疗糖尿病经验[J].浙江中医杂志,2011,46(2):88-89. 被引量：1
-
4朱恒田,丁桂华,韩春玉.幽门螺旋杆菌感染胃部疾病的研究进展[J].中国卫生工程学,2000(2):26-28.
-
5黄长乐,赵文霞.中医药治疗肝纤维化进展[J].中医临床研究,2014,6(2):146-147. 被引量：15
-
6喻辉,黄肖华,易生辉.中药防治下肢深静脉血栓形成的研究进展[J].大众科技,2015,17(1):96-97. 被引量：5
-
7樊可民.青少年慢性乙型肝炎的心理护理[J].现代医药卫生,2003,19(1):102-102.
-
8马玉玲,林松,陆晓,万里,阎月英,陈绍良,段宝祥,周士枋.一氧化氮合成酶抑制剂对麻醉犬等长收缩运动的血流动力学影响[J].心血管康复医学杂志,2003,12(2):119-121.
-
9林松,陆晓,马玉玲,万里,阎月英,陈绍良,段宝祥,周士枋.一氧化氮合成酶抑制剂对等长收缩运动血流动力学影响[J].江苏医药,2002,28(10):741-742.
-
10蔡乙明,马虹,王立军.血管紧张素1-7对高血压大鼠血压一氧化氮及血小板P-选择素的影响[J].中华老年医学杂志,2005,24(5):376-377. 被引量：1
